Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein

Hirofumi Kawakubo, Elena Brachtel, Tetsu Hayashida, Giminna Yeo, Joshua Kish, Alona Muzikansky, Paul D. Walden, Shyamala Maheswaran

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The B-cell translocation gene-2 (BTG2) is present in the nuclei of epithelial cells in many tissues, including the mammary gland where its expression is regulated during glandular proliferation and differentiation in pregnancy. In immortalized mammary epithelial cells and breast cancer cells, BTG2 protein localized predominantly to the nucleus and cytoplasm, respectively. The highly conserved domains (BTG boxes A, B, and C) were required for regulating localization, suppression of cyclin D1 and growth inhibitory function of BTG2. Expression analysis of BTG2 protein in human breast carcinoma (n = 148) revealed the loss of nuclear expression in 46% of tumors, whereas it was readily detectable in the nuclei of adjacent normal glands. Loss of nuclear BTG2 expression in estrogen receptor-α (ERα)-positive breast tumors correlated significantly with increased histologic grade and tumor size. Consistent with its ability to suppress cyclin D1 transcription, loss of nuclear BTG2 expression in ER-positive breast carcinomas showed a significant correlation with cyclin D1 protein overexpression, suggesting that loss of BTG2 may be a factor involved in deregulating cyclin D1 expression in human breast cancer.

Original languageEnglish
Pages (from-to)7075-7082
Number of pages8
JournalCancer Research
Volume66
Issue number14
DOIs
Publication statusPublished - 2006 Jul 15
Externally publishedYes

Fingerprint

Cyclin D1
Estrogen Receptors
B-Lymphocytes
Breast Neoplasms
Genes
Neoplasms
Proteins
Epithelial Cells
Gene Expression
Human Mammary Glands
Cytoplasm
Breast
Pregnancy
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein. / Kawakubo, Hirofumi; Brachtel, Elena; Hayashida, Tetsu; Yeo, Giminna; Kish, Joshua; Muzikansky, Alona; Walden, Paul D.; Maheswaran, Shyamala.

In: Cancer Research, Vol. 66, No. 14, 15.07.2006, p. 7075-7082.

Research output: Contribution to journalArticle

Kawakubo, Hirofumi ; Brachtel, Elena ; Hayashida, Tetsu ; Yeo, Giminna ; Kish, Joshua ; Muzikansky, Alona ; Walden, Paul D. ; Maheswaran, Shyamala. / Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein. In: Cancer Research. 2006 ; Vol. 66, No. 14. pp. 7075-7082.
@article{8eb18838682d4666b38fe1512058d2d6,
title = "Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein",
abstract = "The B-cell translocation gene-2 (BTG2) is present in the nuclei of epithelial cells in many tissues, including the mammary gland where its expression is regulated during glandular proliferation and differentiation in pregnancy. In immortalized mammary epithelial cells and breast cancer cells, BTG2 protein localized predominantly to the nucleus and cytoplasm, respectively. The highly conserved domains (BTG boxes A, B, and C) were required for regulating localization, suppression of cyclin D1 and growth inhibitory function of BTG2. Expression analysis of BTG2 protein in human breast carcinoma (n = 148) revealed the loss of nuclear expression in 46{\%} of tumors, whereas it was readily detectable in the nuclei of adjacent normal glands. Loss of nuclear BTG2 expression in estrogen receptor-α (ERα)-positive breast tumors correlated significantly with increased histologic grade and tumor size. Consistent with its ability to suppress cyclin D1 transcription, loss of nuclear BTG2 expression in ER-positive breast carcinomas showed a significant correlation with cyclin D1 protein overexpression, suggesting that loss of BTG2 may be a factor involved in deregulating cyclin D1 expression in human breast cancer.",
author = "Hirofumi Kawakubo and Elena Brachtel and Tetsu Hayashida and Giminna Yeo and Joshua Kish and Alona Muzikansky and Walden, {Paul D.} and Shyamala Maheswaran",
year = "2006",
month = "7",
day = "15",
doi = "10.1158/0008-5472.CAN-06-0379",
language = "English",
volume = "66",
pages = "7075--7082",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein

AU - Kawakubo, Hirofumi

AU - Brachtel, Elena

AU - Hayashida, Tetsu

AU - Yeo, Giminna

AU - Kish, Joshua

AU - Muzikansky, Alona

AU - Walden, Paul D.

AU - Maheswaran, Shyamala

PY - 2006/7/15

Y1 - 2006/7/15

N2 - The B-cell translocation gene-2 (BTG2) is present in the nuclei of epithelial cells in many tissues, including the mammary gland where its expression is regulated during glandular proliferation and differentiation in pregnancy. In immortalized mammary epithelial cells and breast cancer cells, BTG2 protein localized predominantly to the nucleus and cytoplasm, respectively. The highly conserved domains (BTG boxes A, B, and C) were required for regulating localization, suppression of cyclin D1 and growth inhibitory function of BTG2. Expression analysis of BTG2 protein in human breast carcinoma (n = 148) revealed the loss of nuclear expression in 46% of tumors, whereas it was readily detectable in the nuclei of adjacent normal glands. Loss of nuclear BTG2 expression in estrogen receptor-α (ERα)-positive breast tumors correlated significantly with increased histologic grade and tumor size. Consistent with its ability to suppress cyclin D1 transcription, loss of nuclear BTG2 expression in ER-positive breast carcinomas showed a significant correlation with cyclin D1 protein overexpression, suggesting that loss of BTG2 may be a factor involved in deregulating cyclin D1 expression in human breast cancer.

AB - The B-cell translocation gene-2 (BTG2) is present in the nuclei of epithelial cells in many tissues, including the mammary gland where its expression is regulated during glandular proliferation and differentiation in pregnancy. In immortalized mammary epithelial cells and breast cancer cells, BTG2 protein localized predominantly to the nucleus and cytoplasm, respectively. The highly conserved domains (BTG boxes A, B, and C) were required for regulating localization, suppression of cyclin D1 and growth inhibitory function of BTG2. Expression analysis of BTG2 protein in human breast carcinoma (n = 148) revealed the loss of nuclear expression in 46% of tumors, whereas it was readily detectable in the nuclei of adjacent normal glands. Loss of nuclear BTG2 expression in estrogen receptor-α (ERα)-positive breast tumors correlated significantly with increased histologic grade and tumor size. Consistent with its ability to suppress cyclin D1 transcription, loss of nuclear BTG2 expression in ER-positive breast carcinomas showed a significant correlation with cyclin D1 protein overexpression, suggesting that loss of BTG2 may be a factor involved in deregulating cyclin D1 expression in human breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=33746898960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746898960&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-0379

DO - 10.1158/0008-5472.CAN-06-0379

M3 - Article

C2 - 16849553

AN - SCOPUS:33746898960

VL - 66

SP - 7075

EP - 7082

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 14

ER -